Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.98 HKD | 0.00% | -4.25% | +4.49% |
15/04 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
15/04 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |
- Stock Market
- Equities
- 1477 Stock
- News Ocumension Therapeutics
- MarketScreener Strategies